| Subject: | FDA Releases Initial Communication about Cardiac Science Corp. Powerheart and CardioVive Automated External Defibrillators |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Mon, 23 Nov 2009 - 10:00 am |
| Cardiac Science Corporation has received multiple complaints related to defective components in the Powerheart and CardioVive Automated External Defibrillators (AEDs) that indicate the affected devices may not deliver electric shocks and that the devices' self-test may not detect the defect in advance of their use. Cardiac Science Powerheart and CardioVive Automated External Defibrillator(AED) G3 Series manufactured between August 2003 and August 2009. These devices are used for... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert! provides immediate notification of regulatory body legislation impacting the healthcare industry, helping you to meet regulatory compliance. Subscribers are notified of any new or revised regulations, provided with a summary of the regulation, followed by an implementation action plan and/or policy. Designed as an e-mail "push" method for rapid customer notification of healthcare compliance issues, paired with interpretative analysis and practical application, the StayAlert!® Virtual Compliance Administrator™ saves you time and money. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
